Evidence map›Paper›PMID 39198700›Full record

ArticleNature chemistry2024

A metalloenzyme platform for catalytic asymmetric radical dearomatization.

Wenzhen Fu, Yue Fu, Yunlong Zhao, Huanan Wang, Peng Liu, Yang Yang

Abstract read
In one paragraph

Article in Nature chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Protein engineering: status report.Protein engineering, design & selection : PEDS · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wenzhen FuDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.ORCID http://orcid.org/0000-0002-8454-4720
Yue Fu *Department of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0003-3085-7817
Yunlong Zhao *Department of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.ORCID http://orcid.org/0009-0009-0330-6885
Huanan WangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA.
Peng LiuDepartment of Chemistry, University of Pittsburgh, Pittsburgh, PA, USA. pengliu@pitt.edu.ORCID http://orcid.org/0000-0002-8188-632X
Yang YangDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA, USA. yang@chem.ucsb.edu.ORCID http://orcid.org/0000-0002-4956-2034

Funding

Computational Models for Reactivity and Selectivity in Transition Metal-Catalyzed Olefin FunctionalizationR35GM128779 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Peng Liu · 2018 to 2026
$2.9M
An Evolvable Metalloenzyme Platform for Stereoselective Radical BiocatalysisR35GM147387 · NIGMS · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI Yang Yang · 2022 to 2026
$2.0M
National Science Foundation (NSF) DMR-1933487National Science Foundation (NSF) DMR-2308708National Science Foundation (NSF) OAC-2138259NIGMS NIH HHS R35 GM128779NIGMS NIH HHS R35 GM147387U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM128779U.S. Department of Health & Human Services | National Institutes of Health (NIH) R35GM147387
6 · The paper itself

Abstract

Catalytic asymmetric dearomatization represents a powerful means to convert flat aromatic compounds into stereochemically well-defined three-dimensional molecular scaffolds. Using new-to-nature metalloredox biocatalysis, we describe an enzymatic strategy for catalytic asymmetric dearomatization via a challenging radical mechanism that has eluded small-molecule catalysts. Enabled by directed evolution, new-to-nature radical dearomatases P450

Identifiers

PMID39198700
PMCPMC11840339

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.